Enhanced excitation-coupled Ca2+ entry induces nuclear translocation of NFAT and contributes to IL-6 release from myotubes from patients with central core disease

Human Molecular Genetics

Volumn 20, Issue 3, 2011, Pages 589-600

  Treves, Susan ^a,b   Vukcevic, Mirko ^a   Jeannet, Pierre Yves ^c   Levano, Soledad ^a   Girard, Thierry ^a   Urwyler, Albert ^a   Fischer, Dirk ^a,d   Voit, Thomas ^e   Jungbluth, Heinz ^f,g   Lillis, Sue ^h   Muntoni, Francesco ⁱ   Quinlivan, Ros ^j   Sarkozy, Anna ^k   Bushby, Kate ^k   Zorzato, Francesco ^a,b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF FERRARA   (Italy)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f EVELINA LONDON CHILDREN S HOSPITAL   (United Kingdom)

^g KING'S COLLEGE LONDON   (United Kingdom)

^h GUY S HOSPITAL   (United Kingdom)

ⁱ UNIVERSITY COLLEGE LONDON   (United Kingdom)

^j ROBERT JONES AND AGNES HUNT ORTHOPAEDIC HOSPITAL   (United Kingdom)

^k NEWCASTLE UNIVERSITY   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIHYDROPYRIDINE RECEPTOR; CALCIUM ION; INTERLEUKIN 6; RYANODINE RECEPTOR; TRANSCRIPTION FACTOR NFAT;

ARTICLE; CELL MEMBRANE DEPOLARIZATION; CENTRAL CORE DISEASE; CONTROLLED STUDY; CYTOKINE RELEASE; GENE MUTATION; HUMAN; MALIGNANT HYPERTHERMIA; MYOTUBE; PRIORITY JOURNAL; SARCOLEMMA; SARCOPLASMIC RETICULUM;

CALCIUM; CELLS, CULTURED; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; HUMANS; INTERLEUKIN-6; MALIGNANT HYPERTHERMIA; MICROSCOPY, FLUORESCENCE; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; MUTATION; MYOPATHY, CENTRAL CORE; NFATC TRANSCRIPTION FACTORS; POLYMERASE CHAIN REACTION; REACTIVE NITROGEN SPECIES;

EID: 78651073564     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddq506     Document Type: Article

References (52)

1. Fleischer, S. and Inui, M. (1989) Biochemistry and biophysics of excitation-contraction coupling. Annu. Rev. Biophys. Biophys. Chem., 18, 333-364.
2. Rios, E. and Pizarro, G. (1991) Voltage sensor of excitation-contraction coupling in skeletal muscle. Physiol. Rev., 71, 849-908.
3. Franzini-Armstrong, C. and Jorgensen, A.O. (1994) Structure and development of E-C coupling units in skeletal muscle. Annu. Rev. Physiol., 56, 509-534.
4. 2+ release channels: does diversity in form equal diversity in function? Physiol. Rev., 76, 1027-1071.
5. Nakai, J., Dirksen, R.T., Nguyen, H.T., Pessah, I.N., Beam, K.G. and Allen, P.D. (1996) Enhanced dihydropyridine receptor channel activity in the presence of ryanodine receptor. Nature, 380, 72-75.
6. Wilmshurst, J.M., Lillis, S., Zhou, H., Pillay, K., Henderson, H., Kress, W., Müller, C.R., Ndondo, A., Cloke, V., Cullup, T. et al. (2010) RYR1 mutations are a common cause of congenital myopathies with central nuclei. Ann. Neurol., 68, 717-726.
7. Clarke, N.F., Waddell, L.B., Cooper, S.T., Perry, M., Smith, R.L., Kornberg, A.J., Muntoni, F., Lillis, S., Straub, V., Bushby, K. et al. (2010) Recessive mutations in RYR1 are a common cause of congenital fiber type disproportion. Hum. Mutat., 31, E1544-E1550.
8. Ducreux, S., Zorzato, F., Müller, C., Sewry, C., Muntoni, F., Quinlivan, R., Restagno, G., Girard, T. and Treves, S. (2004) Effect of ryanodine receptor mutations on IL-6 release and intracellular calcium homeostasis in human myotubes from malignant hyperthermia susceptible individuals and patients affected by central core disease. J. Biol. Chem., 279, 43838-43846.
9. 2+ release channel function and severe central core disease. Proc. Natl Acad. Sci. USA, 96, 4164-4169.
10. Tilgen, N., Zorzato, F., Halliger-Keller, B., Muntoni, F., Sewry, C., Palmucci, L.M., Schneider, C., Hauser, E., Lehmann-Horn, F., Müller, C.R. and Treves, S. (2001) Identification of four novel mutations in the C-terminal membrane spanning domain of the ryanodine receptor 1: association with central core disease and alteration of calcium homeostasis. Hum. Mol. Genet., 10, 2879-2887.
11. Treves, S., Anderson, A.A., Ducreux, S., Divet, A., Bleunven, C., Grasso, C., Paesante, S. and Zorzato, F. (2005) Ryanodine receptor 1 mutations, dysregulation of calcium homeostasis and neuromuscular disorders. Neuromuscul. Disord., 15, 577-587.
12. Avila, G., O'Brien, J.J. and Dirksen, R.T. (2001) Excitation-contraction uncoupling by a human central core disease mutation in the ryanodine receptor. Proc. Natl Acad. Sci. USA, 98, 4215-4220.
13. Avila, G. and Dirksen, R.T. (2001) Functional effects of central core disease mutations in the cytoplasmic region of the skeletal muscle ryanodine receptor. J. Gen. Physiol., 118, 277-290.
14. Avila, G., O'Connell, K. and Dirksen, R.T. (2003) The pore region of the skeletal muscle ryanodine receptor is a primary locus for excitation-contraction uncoupling in central core disease. J. Gen. Physiol., 121, 277-286.
15. 2+ handling caused by malignant hyperthermia and central core disease mutations in RyR1. Biophys. J., 87, 3193-3204.
16. Treves, S., Jungbluth, H., Muntoni, F. and Zorzato, F. (2008) Congenital muscle disorders with cores: the ryanodine receptor calcium channel paradigm. Curr. Opin. Pharmacol., 8, 319-326.
17. Rios, E. (2010) The cell boundary theorem: a simple law of the control of cytosolic calcium concentration. J. Physiol. Sci., 60, 81-84.
18. Cherednichenko, G., Hurne, A.M., Fessenden, J.D., Lee, E.H., Allen, P.D., Beam, K.G. and Pessah, I.N. (2004) Conformational activation of calcium entry by depolarisation of skeletal muscle myotubes. Proc. Natl Acad. Sci. USA, 101, 15793-15798.
19. 2+ entry. J. Gen. Physiol., 133, 79-91.
20. Cherednichenko, G., Ward, C.W., Feng, W., Cabrales, E., Michaelson, L., Samso, M., López, J.R., Allen, P.D. and Pessah, I.N. (2008) Enhanced excitation-coupled calcium entry (ECCE) in myotubes expressing malignant hyperthermia mutation R163C is attenuated by dantrolene. Mol. Pharmacol., 73, 1203-1212.
21. Yang, T., Allen, P.D., Pessah, I.N. and Lopez, J.R. (2007) Enhanced excitation-coupled calcium entry in myotubes is associated with expression of RyR1 malignant hyperthermia mutations. J. Biol. Chem., 282, 37471-37478.
22. 2+ entry in skeletal muscle. J. Physiol., 587, 3139-3147.
23. Olson, E.N. and Williams, R.S. (2000) Remodeling muscles with calcineurin. Bioessays, 22, 510-519.
24. Liu, Y., Randall, W.R. and Schneider, M.F. (2005) Activity-dependent and -independent nuclear fluxes of HDAC4 mediated by different kinases in adult skeletal muscle. J. Cell. Biol., 168, 887-897.
25. Stamler, J.S. and Meissner, G. (2001) Physiology of nitric oxide in skeletal muscle. Physiol. Rev., 81, 209-237.
26. Zhou, H., Yamaguchi, N., Xu, L., Wang, Y., Sewry, C., Jungbluth, H., Zorzato, F., Bertini, E., Muntoni, F., Meissner, G. and Treves, S. (2006) Characterization of recessive RYR1 mutations in core myopathies. Hum. Mol. Genet., 15, 2791-2803.
27. Yang, T., Esteve, E., Pessah, I.N., Molinski, T.F., Allen, P.D. and López, J.R. (2007) Elevated resting [Ca(2+)](i) in myotubes expressing malignant hyperthermia RyR1 cDNAs is partially restored by modulation of passive calcium leak from the SR. Am. J. Physiol. Cell. Physiol., 292, C1591-C1598.
28. Reck-Peterson, S.L., Derr, N.D. and Stuurman, N. (2010) Imaging single molecules using total internal reflection fluorescence microscopy (TIRFM). Cold. Spring. Harb. Protoc., [Epub a head of print].
29. 2+ release channel of sarcoplasmic reticulum. J. Biol. Chem., 261, 6300-6306.
30. 2+ release channel from skeletal muscle sarcoplasmic reticulum. Mol. Pharmacol., 42, 1049-1067.
31. Catterall, W.A., Perez-Reyes, E., Snutch, T.P. and Striessnig, J. (2005) International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels. Pharmacol. Rev., 57, 411-425.
32. 2+ entry blockers. Jpn J. Pharmacol., 81, 253-258.
33. Durham, W.J., Aracena-Parks, P., Long, C., Rossi, A.E., Goonasekera, S.A., Boncompagni, S., Galvan, D.L., Gilman, C.P., Baker, M.R., Shirokova, N. et al. (2008) RyR1 S-nitrosylation underlies environmental heat stroke and sudden death in Y522S RyR1 knockin mice. Cell, 133, 53-65.
34. Leikert, J.F., Räthel, T.R., Müller, C., Vollmar, A.M. and Dirsch, V.M. (2001) Reliable in vitro measurement of nitric oxide released from endothelial cells using low concentrations of the fluorescent probe 4,5-diaminofluorescein. FEBS Lett., 506, 131-134.
35. Furfine, E.S., Harmon, M.F., Paith, J.E. and Garvey, E.P. (1993) Selective inhibition of constitutive nitric oxide synthase by L-NG-nitroarginine. Biochemistry, 32, 8512-8517.
36. Drenning, J.A., Lira, V.A., Simmons, C.G., Soltow, Q.A., Sellman, J.E. and Criswell, D.S. (2008) Nitric oxide facilitates NFAT-dependent transcription in mouse myotubes. Am. J. Physiol. Cell. Physiol., 294, C1088-C1095.
37. Valdés, J.A., Gaggero, E., Hidalgo, J., Leal, N., Jaimovich, E. and Carrasco, M.A. (2008) NFAT activation by membrane potential follows a calcium pathway distinct from other activity-related transcription factors in skeletal muscle cells. Am. J. Physiol. Cell. Physiol., 294, C715-C725.
38. Rosenberg, P., Hawkins, A., Stiber, J., Shelton, J.M., Hutcheson, K., Basel-Duby, R., Shin, D.M., Yan, Z. and Williams, R.S. (2004) TRPC3 channels confer cellular memory of recent neuromuscular activity. Proc. Natl Acad. Sci. USA, 101, 9387-9392.
39. 2+]i. Am. J. Physiol. Cell. Physiol., 288, C606-C612.
40. Parekh, A. and Penner, R. (1997) Store depletion and calcium influx. Physiol. Rev., 77, 901-926.
41. 2+ influx. J. Biol. Chem., 269, 12645-12653.
42. Sheng, J.Z., Wang, D. and Braun, A.P. (2005) DAF-FM (4-amino-5-methylamino-2′,7′-difluorofluorescein) diacetate detects impairment of agonist-stimulated nitric oxide synthesis by elevated glucose in human vascular endothelial cells: reversal by vitamin C and L-sepiapterin. J. Pharmacol. Exp. Ther., 315, 931-940.
43. Conte, A. (2003) Physiologic pH changes modulate calcium ion dependence of brain nitric oxide synthase in Carassius auratus. Biochim. Biophys. Acta, 1619, 29-38.
44. 2+/calmodulin-regulated nitric oxide synthases. Cell Calcium, 13, 427-434.
45. Abbott, K.L., Friday, B.B., Thaloor, D., Murphy, T.J. and Pavlath, G.K. (1998) Activation and cellular localization of the cyclosporine A-sensitive transcription factor NF-AT in skeletal muscle cells. Mol. Biol. Cell., 9, 2905-2916.
46. Shen, T., Liu, Y., Randall, W.R. and Schneider, M.F. (2006) Parallel mechanisms for resting nucleo-cytoplasmic shuttling and activity dependent translocation provide dual control of transcriptional regulators HDAC and NFAT in skeletal muscle fiber type plasticity. J. Muscle Res. Cell. Motil., 27, 405-411.
47. Allen, D.L., Uyenishi, J.J., Cleary, A.S., Mehan, R.S., Lindsay, S.F. and Reed, J.M. (2010) Calcineurin activates interleukin-6 transcription in mouse skeletal muscle in vivo and in C2C12 myotubes in vitro. Am. J. Physiol. Regul. Integr. Comp. Physiol., 298, R198-R210.
48. Nilsson, L.M., Sun, Z.W., Nilsson, J., Nordström, I., Chen, Y.W., Molkentin, J.D., Wide-Swensson, D., Hellstrand, P., Lydrup, M.L. and Gomez, M.F. (2007) Novel blocker of NFAT activation inhibits IL-6 production in human myometrial arteries and reduces vascular smooth muscle cell proliferation. Am. J. Cell. Physiol., 292, C1167-C1178.
49. Tsujinaka, T., Fujita, J., Ebisui, C., Yano, M., Kominami, E., Suzuki, K., Tanaka, K., Katsume, A., Ohsugi, Y., Shiozaki, H. and Monden, M. (1996) Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice. J. Clin. Invest., 97, 244-249.
50. Ebisui, C., Tsujinaka, T., Morimoto, T., Kan, K., Iijima, S., Yano, M., Kominami, E., Tanaka, K. and Monden, M. (1995) Interleukin-6 induces proteolysis by activating intracellular proteases (cathepsins B and L, proteasome) in C2C12 myotubes. Clin. Sci. (Lond.)., 89, 431-439.
51. Levano, S., Vukcevic, M., Singer, M., Matter, A., Treves, S., Urwyler, A. and Girard, T. (2009) Increasing the number of diagnostic mutations in malignant hyperthermia. Hum. Mutat., 30, 590-598.
52. Treves, S., Vukcevic, M., Griesser, J., Franzini-Armstrong, C., Zhu, M.X. and Zorzato, F. (2010) Agonist activated calcium influx occurs at stable plasmalemma-endoplasmic reticulum junctions. J. Cell Sci., 123, 4170-4181.